Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Association Between Systemic Inflammation and Individual Symptoms of Depression: A Pooled Analysis of 15 Population-Based Cohort Studies.

The American journal of psychiatry

Frank P, Jokela M, Batty GD, Cadar D, Steptoe A, Kivimäki M.
PMID: 34645276
Am J Psychiatry. 2021 Dec;178(12):1107-1118. doi: 10.1176/appi.ajp.2021.20121776. Epub 2021 Oct 14.

OBJECTIVE: Evidence from anti-inflammatory drug trials for the treatment of depression has been inconsistent. This may be ascribed to the differing symptom-specific effects of inflammation. Accordingly, the authors explored the associations between systemic inflammation and an array of individual...

Cite
Frank P, Jokela M, Batty GD, et al. Association Between Systemic Inflammation and Individual Symptoms of Depression: A Pooled Analysis of 15 Population-Based Cohort Studies. Am J Psychiatry. 2021;178(12):1107-1118doi: 10.1176/appi.ajp.2021.20121776.
Frank, P., Jokela, M., Batty, G. D., Cadar, D., Steptoe, A., & Kivimäki, M. (2021). Association Between Systemic Inflammation and Individual Symptoms of Depression: A Pooled Analysis of 15 Population-Based Cohort Studies. The American journal of psychiatry, 178(12), 1107-1118. https://doi.org/10.1176/appi.ajp.2021.20121776
Frank, Philipp, et al. "Association Between Systemic Inflammation and Individual Symptoms of Depression: A Pooled Analysis of 15 Population-Based Cohort Studies." The American journal of psychiatry vol. 178,12 (2021): 1107-1118. doi: https://doi.org/10.1176/appi.ajp.2021.20121776
Frank P, Jokela M, Batty GD, Cadar D, Steptoe A, Kivimäki M. Association Between Systemic Inflammation and Individual Symptoms of Depression: A Pooled Analysis of 15 Population-Based Cohort Studies. Am J Psychiatry. 2021 Dec;178(12):1107-1118. doi: 10.1176/appi.ajp.2021.20121776. Epub 2021 Oct 14. PMID: 34645276.
Copy Download .nbib Format: NLM
Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics.

Nature communications

Gordillo-Marañón M, Zwierzyna M, Charoen P, Drenos F, Chopade S, Shah T, Engmann J, Chaturvedi N, Papacosta O, Wannamethee G, Wong A, Sofat R, Kivimaki M, Price JF, Hughes AD, Gaunt TR, Lawlor DA, Gaulton A, Hingorani AD, Schmidt AF, Finan C.
PMID: 34675202
Nat Commun. 2021 Oct 21;12(1):6120. doi: 10.1038/s41467-021-25731-z.

Drug target Mendelian randomization (MR) studies use DNA sequence variants in or near a gene encoding a drug target, that alter the target's expression or function, as a tool to anticipate the effect of drug action on the same...

Cite
Gordillo-Marañón M, Zwierzyna M, Charoen P, et al. Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics. Nat Commun. 2021;12(1):6120doi: 10.1038/s41467-021-25731-z.
Gordillo-Marañón, M., Zwierzyna, M., Charoen, P., Drenos, F., Chopade, S., Shah, T., Engmann, J., Chaturvedi, N., Papacosta, O., Wannamethee, G., Wong, A., Sofat, R., Kivimaki, M., Price, J. F., Hughes, A. D., Gaunt, T. R., Lawlor, D. A., Gaulton, A., Hingorani, A. D., Schmidt, A. F., & Finan, C. (2021). Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics. Nature communications, 12(1), 6120. https://doi.org/10.1038/s41467-021-25731-z
Gordillo-Marañón, María, et al. "Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics." Nature communications vol. 12,1 (2021): 6120. doi: https://doi.org/10.1038/s41467-021-25731-z
Gordillo-Marañón M, Zwierzyna M, Charoen P, Drenos F, Chopade S, Shah T, Engmann J, Chaturvedi N, Papacosta O, Wannamethee G, Wong A, Sofat R, Kivimaki M, Price JF, Hughes AD, Gaunt TR, Lawlor DA, Gaulton A, Hingorani AD, Schmidt AF, Finan C. Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics. Nat Commun. 2021 Oct 21;12(1):6120. doi: 10.1038/s41467-021-25731-z. PMID: 34675202; PMCID: PMC8531035.
Copy Download .nbib Format: NLM
Organizational Justice and Long-term Metabolic Trajectories: A 25-Year Follow-up of the Whitehall II Cohort.

The Journal of clinical endocrinology and metabolism

Varga TV, Xu T, Kivimäki M, Mehta AJ, Rugulies R, Rod NH.
PMID: 34596687
J Clin Endocrinol Metab. 2022 Jan 18;107(2):398-409. doi: 10.1210/clinem/dgab704.

CONTEXT: Organizational justice has been linked to lower risk of several chronic conditions among employees, but less is known about the long-term mechanisms underlying this risk reduction.OBJECTIVE: To assess whether self-reported organizational justice is associated with individual and composite...

Cite
Varga TV, Xu T, Kivimäki M, et al. Organizational Justice and Long-term Metabolic Trajectories: A 25-Year Follow-up of the Whitehall II Cohort. J Clin Endocrinol Metab. 2022;107(2):398-409doi: 10.1210/clinem/dgab704.
Varga, T. V., Xu, T., Kivimäki, M., Mehta, A. J., Rugulies, R., & Rod, N. H. (2022). Organizational Justice and Long-term Metabolic Trajectories: A 25-Year Follow-up of the Whitehall II Cohort. The Journal of clinical endocrinology and metabolism, 107(2), 398-409. https://doi.org/10.1210/clinem/dgab704
Varga, Tibor V, et al. "Organizational Justice and Long-term Metabolic Trajectories: A 25-Year Follow-up of the Whitehall II Cohort." The Journal of clinical endocrinology and metabolism vol. 107,2 (2022): 398-409. doi: https://doi.org/10.1210/clinem/dgab704
Varga TV, Xu T, Kivimäki M, Mehta AJ, Rugulies R, Rod NH. Organizational Justice and Long-term Metabolic Trajectories: A 25-Year Follow-up of the Whitehall II Cohort. J Clin Endocrinol Metab. 2022 Jan 18;107(2):398-409. doi: 10.1210/clinem/dgab704. PMID: 34596687.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries